Floatz logo

PREDNISONE TABLETS

TP53

Masonic Cancer Center, University of MinnesotaSmall moleculePhase 2Active
B
58/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
81/ 100

Competitive context

24 Active assets in the TP53 cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Masonic Cancer Center, University of Minnesota
Phase 2B
DEXAMETHASONE
The First Affiliated Hospital with Nanjing Medical University
Phase 2B
Inno-206
Masonic Cancer Center, University of Minnesota
Phase 2B
Epirubicin
The First Affiliated Hospital of Xiamen University
Phase 2CCC
Glofitamab
The First Affiliated Hospital with Nanjing Medical University
Phase 2CCC

View all 24 →

Same molecule, other indications

PREDNISONE TABLETS is also rated in:

Recurrent Adult T-cell Leukemia/LymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
diffuse large B-cell lymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
metastatic prostate carcinomaDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →